Lapatinib Completed Phase 2 Trials for Malignancies Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01013740Lapatinib in Combination With Vinorelbine
NCT01128543Lapatinib in Combination With Vinorelbine